CannMed Coffee Talk
Conversations with the leading minds in cannabis science, medicine, cultivation, and safety testing.
- Indexed episodes, last 90 days
- 4
- Latest publication
- Sep 23, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 12, 2026
Latest episodes
Synthetic Cannabinoids and Their Effects on T Cells with Lindsay Avery, PhD (opens the original)
Read excerpt
Lindsay Avery is an immunologist specializing in T cell signaling. As a professor at Saint Michael’s College, her primary focus is training future scientists at the undergraduate level. In collaboration with fellow Saint Michael’s professor and CannMed Advisor Mark Scialdone, Lindsay and her students conducted basic drug discovery research on synthetic cannabinoids through course-based undergraduate research experiences (CUREs). Lindsay presented her team’s findings as at CannMed 26 in a poster
Dispersed Lighting and Bud Grade Optimization with David Hawley, PhD (opens the original)
Read excerpt
David Hawley is Principal Scientist at Fluence, where he steers the company’s global Cannabis Crop Sciences program. His team’s research, which often appears in peer-reviewed publications, has identified specific and diverse lighting strategies that consider crop yield, morphology, quality, and economics that maximize commercial growers’ objectives. At CannMed 26, David presented a poster titled, “ Two novel lighting strategies to reduce operational expenses while boosting quality and yield ” Du
The Cognitive Trade-Offs of Cannabis and ADHD with Carrie Cuttler, PhD (opens the original)
Read excerpt
Dr. Carrie Cuttler is currently a Co-Director of the Cannabis Research Center (CRC) at Washington State University Center (WSU). She is also an Associate Professor in the Department of Psychology at WSU. Carrie directs research in The Health and Cognition (THC) lab that focuses on examining both the beneficial and detrimental effects of cannabis and cannabinoids. Her recent work focuses on examining the therapeutic potential of cannabigerol (CBG), as well as effects of chronic cannabis use and a
Identifying the Skunk Genes in Cannabis with Manny Maminakis (opens the original)
Read excerpt
Manny Maminakis is the inventor and CEO of Cannamatrix INC, a cannabis bioinfomratics platform. Prior to Cannamatrix, Manny spent 12 years in the cannabis industry as an award winning cannabis cultivator and edible chef. At CannMed 26, he presented a poster titled “Computational Identification of Volatile Sulfur Compound Synthase Homologs in Cannabis sativa Using Profile Hidden Markov Models” During our conversation, we discuss: What volatile sulfur compounds (VSCs) are and why they give certain
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.